Continuous Manufacturing for Composite ОРД: Multi-Formula Stripe Coating

The consumer expectation for Oral Dissolvable Films (ОРД) is evolving. The market is moving beyond simple "convenience" toward enhanced "experience and function." This shift drives demand for multi-flavor combinations, distinct functional segmentation, and precise dosage pairings.

For фармацевтический companies and CDMOs, this presents a paradox: the product morphology is becoming more complex, yet the production system must remain stable, validatable, and scalable. The engineering challenge lies in reconciling these opposing forces.

---

The Engineering Pain Points: Why Traditional Methods Fail

1. The "Multi-Pass" Trap: Efficiency and Validation Risks

Traditionally, realizing a composite ОРД (multiple formulas in one strip) relies on multi-layer or sequential coating processes. In this scenario, every distinct layer usually requires a full drying cycle before the next formulation can be applied. This reliance on sequential processing introduces three critical engineering deficits:

• Reduced Takt Time: Production speed is throttled by the necessity of multiple drying passes.
• Narrowed Process Windows: Errors stack up. A minor deviation in the first layer’s surface tension can result in catastrophic defects in the second layer.
• Validation Burden: Cleaning validation (CV) frequency and complexity increase exponentially with each additional pass and fluid handling system.

2. The Compatibility & Migration Challenge

Combining multiple formulations is not merely about placing two liquids adjacent to one another. It involves complex fluid dynamics. Differing rheologies, solvent systems, solid contents, and drying rates create instability at the interface. The more complex the product, the more critical it becomes to reduce unnecessary steps in the ОРД manufacturing process to minimize migration risks.

---

The Huanghai Solution: Single-Layer Multi-Formula Stripe Coating

To achieve true continuous manufacturing for composite ODFs, Huanghai Pharmaceutical Instruments advocates for Simultaneous Multi-Formula Stripe Coating. This technology transforms "multi-formula" from a sequential, multi-step burden into a "single-pass" capability.

The Core Mechanism:
Our patented coating head technology allows for the simultaneous application of two distinct formulations within a single coating layer. The ratio between the strips is fully adjustable.

Note: If the formulation requires more than two distinct active ingredients that are chemically incompatible in the liquid phase, this stripe coating can still be combined with subsequent layers—but the primary complexity is handled in the first pass.

Primary Application Scenarios

This configuration is specifically engineered for high-value differentiation:

• Dual-Flavor/Experiential Products: Example: A Mint strip paired with a Fruit strip for sequential flavor release.
• Functional Segmentation: A primary API zone coupled with an auxiliary functional zone (e.g., pH modifiers or cooling agents).
• Visual Identification: Color-coding distinct strips for brand recognition or dosage strength verification.
• Scale-Up Sensitive Projects: Formulations that degrade if exposed to heat twice. Single-pass processing protects heat-sensitive APIs.

---

Engineering Implementation: The "Client Parameter Checklist"

Moving from R&D to production requires precise control over the physical properties of both fluids. When configuring a Huanghai MJ Series machine for stripe coating, we focus on matching the following parameters:

• Rheology Matching: Ensuring viscosity, solid content, and solvent systems of Formula A and Formula B are compatible to prevent bleeding at the stripe boundary.
• Boundary Stability: Precision control of web tension and pump accuracy to maintain straight, distinct lines.
• Unified Drying Curves: Designing the drying tunnel airflow to accommodate the drying rates of both formulations simultaneously, avoiding the scenario where one strip is over-dried (brittle) while the other remains tacky.

---

Summary

To achieve continuous manufacturing in composite ODFs, the goal is not just "can we stack formulas?" but "can we embed the complexity into the equipment design rather than the manual operation?"

Huanghai’s in-layer stripe coating provides a path aligned with GMP scalability: reducing process steps to a single pass and locking in quality through superior drying and transport stability.

Is your current R&D project facing scale-up bottlenecks due to complex formulations?

Contact our engineering team to review your URS and Line Layout options today.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

Explore related equipment: ОРД film coating machine | фармацевтический тестирование instruments.

---

Frequently Asked Questions

Q: What is the difference between an ОРД film and a трансдермальный пластырь?

A: Oral Dissolving Films (ОРД) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ОРД machine supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ОРД machine?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ОРД production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ОРД equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.

Q: What are the GMP requirements for ОРД production equipment?

A: ОРД manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent стандарты (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ОРД machines meet these стандарты—all product contact surfaces use фармацевтический-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP соответствие documentation.

Q: Can Huanghai machines produce stripe-coated or multi-formula ОРД films?

A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ОРД products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.